Literature DB >> 5128821

The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.

K Miyagi, R Cardinal, I Bossenmaier, C J Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5128821

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  26 in total

Review 1.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

2.  Enzyme aspects of acute intermittent porphyria.

Authors:  D P Tschudy
Journal:  Mol Cell Biochem       Date:  1973-11-15       Impact factor: 3.396

3.  Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.

Authors:  C H Chen; K H Astrin; G Lee; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 4.  Porphobilinogen deaminase gene structure and molecular defects.

Authors:  J C Deybach; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

5.  Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.

Authors:  P M Anderson; R M Reddy; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

6.  Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.

Authors:  S Sassa; G L Zalar; A Kappas
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.

Authors:  L J Strand; U A Meyer; B F Felsher; A G Redeker; H S Marver
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities.

Authors:  M Yamada; M Kondo; M Tanaka; R Okeda; S Hatakeyama; T Fukui; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 9.  Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level.

Authors:  G Romeo
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

10.  Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.

Authors:  A Kappas; H L Bradlow; D R Bickers; A P Alvares
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.